Fonte: Molecular and cellular biochemistry. Unidade: EEFE
Assuntos: FISIOLOGIA, METABOLISMO, HOMEOSTASE, CÁLCIO, HORMÔNIOS GLICOCORTICOIDES, INSUFICIÊNCIA CARDÍACA, FÁRMACOS IMUNOSSUPRESSORES, ANTI-INFLAMATÓRIOS ESTEROIDES, RATOS WISTAR
ABNT
GUIMARÃES, Fabiana de Salvi et al. Dexamethasone-induced cardiac deterioration is associated with both calcium handling abnormalities and calcineurin signaling pathway activation. Molecular and cellular biochemistry, v. 424, n. ja 2017, p. 87-98, 2017Tradução . . Disponível em: https://doi.org/10.1007/s11010-016-2846-3. Acesso em: 31 ago. 2024.APA
Guimarães, F. de S., Moraes, W. M. A. M. de, Bozi, L. H. M., Souza, P. R., Antonio, E. L., Bocalini, D. S., et al. (2017). Dexamethasone-induced cardiac deterioration is associated with both calcium handling abnormalities and calcineurin signaling pathway activation. Molecular and cellular biochemistry, 424( ja 2017), 87-98. doi:10.1007/s11010-016-2846-3NLM
Guimarães F de S, Moraes WMAM de, Bozi LHM, Souza PR, Antonio EL, Bocalini DS, Tucci PJF, Ribeiro DA, Brum PC, Medeiros A. Dexamethasone-induced cardiac deterioration is associated with both calcium handling abnormalities and calcineurin signaling pathway activation [Internet]. Molecular and cellular biochemistry. 2017 ; 424( ja 2017): 87-98.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1007/s11010-016-2846-3Vancouver
Guimarães F de S, Moraes WMAM de, Bozi LHM, Souza PR, Antonio EL, Bocalini DS, Tucci PJF, Ribeiro DA, Brum PC, Medeiros A. Dexamethasone-induced cardiac deterioration is associated with both calcium handling abnormalities and calcineurin signaling pathway activation [Internet]. Molecular and cellular biochemistry. 2017 ; 424( ja 2017): 87-98.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1007/s11010-016-2846-3